EU_Renal_contents.qxp 31/7/07 2:27 pm Page 3
Contents
Cardiovascular Risk
Accuracy of a Home Blood Pressure Monitor Tested in
End-stage Renal Disease Patients 38
Aliza M Thompson, Kazuo Eguchi, Michael E Reznik, Samir S Shah and Thomas G Pickering
Department of Medicine, Behavioural Cardiovascular Health and Hypertension Program, and
Division of Nephrology, Columbia University
Direct Renin Inhibitors – Nuance or Necessity? 41
Liviu Segall,
1
Kerem Atalar
2
and David Goldsmith
3
1. ’C I Parhon’ University Hospital, Romania; 2. St Thomas’ Hospital, London; 3. Guy’s Hospital, London
Dialysis
Fast Transport Status in Peritoneal Dialysis Patients –
Greater Knowledge, Better Treatment 44
Anabela Rodrigues
Nephrology Consultant and Associate Professor of Nephrology, University of Porto
Renal Replacement Therapy in Acute Renal Failure –
What Is Recommended in 2007? 49
Eric Rondeau
Head, Department of Intensive Care Nephrology and Transplantation, Hôpital Tenon, Paris
Transplantation
Organ Quality Determines Outcome after Kidney Transplantation 51
Stefan G Tullius,
1
Mohamed H Sayegh
1,2
and Giuseppe Remuzzi
3
1. Brigham and Women’s Hospital, Harvard Medical School; 2. Children’s Hospital, Harvard Medical School;
3. Ospedali Riuniti and Mario Negri Institute for Pharmacological Research, Bergamo, Italy
Kidney Transplantation 55
Helena Genberg, Lars Wennberg and Gunnar Tydén
Karolinska University Hospital and Karolinska Institute
The Influence of Various Immunosuppressive Regimens on Tolerance
Induction in Transplant Recipients 61
Julien Zuber,
1
Albane Brodin-Sartorius,
1
Eric Thervet
1
and Christophe Legendre
1,2
1. Necker Hospital; 2. René Descartes University, Paris
Nutrition
Present Status and Perspectives in the Treatment of
Malnutrition in Haemodialysis 64
Noël JM Cano
Professor of Nutrition, Clermont-Ferrand University School of Medicine, Montpied Hospital, France
Effect of Growth Hormone on Biomarkers of Nutrition and
Cardiovascular Disease as well as on Quality of Life in
Patients on Chronic Maintenance Haemodialysis 67
Bo Feldt-Rasmussen
Chief of the Division of Nephrology, Rigshospitalet, University of Copenhagen
The Role of Growth Hormone in the Treatment of Malnutrition in
Adult Patients on Chronic Haemodialysis 70
Anne-Marie Kappelgaard,
1
Martin Lange
2
and Meguid El Nahas
3
1. Novo Nordisk A/S, Copenhagen; 2. Novo Nordisk Inc., Princeton, New Jersey;
3. Sheffield Kidney Institute, Northern General Hospital, Sheffield
EUROPEAN RENAL DISEASE 2007 3
Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74